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Experimental Section 
PEG-GNS synthesis. All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and 
used as received unless noted otherwise. Detailed surfactant-free GNS synthesis and 
characterization has been presented elsewhere.1 Briefly, citrate gold seeds were prepared by 
adding 15 ml of 1% trisodium citrate to 100 ml of boiling HAuCl4 (1 mM) under vigorous 
stirring for 15 minutes. GNS were prepared using a seed-mediated method by quickly mixing 
AgNO3 (1 ml, 3 mM) and ascorbic acid (500 µl, 0.1 M) together into 100 ml of HAuCl4 (0.25 
mM) containing HCl (100 µl, 1M) and citrate gold seeds (1 ml, OD520: 2.8) followed by 
filtration using 0.22 µm nitrocellulose membrane. PEG-GNS was prepared by adding final 2 
µM of SHPEG5000 (O-[2-(3-mercaptopropionylamino)ethyl]-O’-methylpolyethylene glycol, 
MW 5000) to freshly synthesized GNS for 10 minutes followed by two centrifugal washes. 
NPs were concentrated by centrifugation to desired concentration (1~5 pmole, 150 µl in PBS) 
before animal use. NPs were examined by TEM (Fei Tecnai G2 Twin, 200 kV) and VIS-NIR 
spectroscopy (Shimadzu UV-3600; Shimadzu corporation, Japan). The NPs’ hydrodynamic 
size and concentration were assessed by nanoparticle tracking analysis (NTA 2.3, Build 0025, 
NanoSight NS500; Nanosight Ltd. UK). 
 
Cranial window implantation and orthotopic brain tumor animal model. The animal 
experiments were carried out in accordance with Duke University Institutional Animal Care 
and Use Committee guidelines. For cerebral microangiogram and photothermal experiment, a 
cranial window chamber was implanted. Female CD-1 nu/nu mice were anesthetized 
(ketamine/xylazine 100/10 mg kg-1 i.p. or isoflurane inhalation) and placed in a stereotaxic 
frame with their body temperature maintained at 37 °C. The scalp and underlying soft tissue 
over the parietal cortex were removed bilaterally. A drill was used to create a rectangular 
cranial window centered on the midsagittal suture that extended from the bregma to the 
lambdoid sutures. The dura mater was excised followed by implantation of human xenograft 
D270 cell suspension (108 cells ml-1, 10 µl) in basement membrane matrix (BD Matrigel 
Matrix, BD Bioscience, Bedford, MA). Following implantation, a glass plate was glued to the 
bone surrounding the cranial window. For non-window tumor animals, mice were implanted 
with human D270-GBM cell line stereotactically through a small burr hole (2 mm right side 
the mid-sagittal suture, 2-3 mm back of the lambdoid suture, 5 mm below skull surface) 1~2 
weeks before the nanoparticle injection. During the imaging, anesthetized mice were placed 
on a heating frame to maintain body temperature at 37 °C. For histology, mice were sacrificed 
with sodium phenobarbital (200 mg kg-1, i.p.). Excised whole brains were placed in Hoeschet 
33342 solution (Life Technology, Grand Island, NY) or snap frozen over liquid nitrogen and 
OCT compound. Cryosectioned samples (7 µm) were acetone fixed and stained with H&E 
(Sigma-Aldrich, St. Louis, MO) or CD-31 antibodies (BD Biosciences, San Jose, CA), 
fluorophore-labeled secondary antibodies (Life Technology, Grand Island, NY), and covered 
with a DAPI mounting medium (Vector Laboratories, Burlingame, CA) followed by imaging 
under MPM. 
 
Multiphoton microscopy imaging and irradiation. The MPM images were recorded using a 
commercial multiphoton microscope (Olympus FV1000; Olympus America, Center Valley, 
PA) with 3 detection channels (420-460 nm, 495-540 nm, 575-630 nm) on photomultiplier 
tubes (Hamamatsu, Bridgewater, NJ). A femtosecond Ti:Sapphire laser (Chameleon Vision II; 
Coherent, Santa Clara, CA) with tunable range 680-1080 nm, 140 fsec pulse width and 80 
MHz repetition rate was used. The laser beam was focused through a 25! 1.05 NA water-
immersion objective (XLPL25XWMP). Depth images were 3D-reconstructed using Fiji or 
Imaris (Bitplane, South Windsor, CT). Tile images were acquired via a motorized stage 
(ProScan III, Prior Scientific, Inc., Rockland, MA) and stitched using FluoView (FV10-ASW). 
For laser irradiation, anesthetized mice were kept on a 37 °C heating stage and exposed to 800 
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nm pulsed laser irradiation (35 mW) on the same MPM. The laser power was measured with a 
thermopile power meter (Newport, Irvine, CA). The treatment was performed by depth 
scanning the area (spot size 500!500 µm2, 10 µs pixel-1, 5 µm per slice).  
 
Photoacoustic computer tomography. The procedures were approved by the Washington 
University at St. Louis Institutional Animal Care and Use Committee. The photoacoustic 
computer tomography (PACT) experiment was performed on a 512-element full-ring 
ultrasonic transducer array.2 The central frequency of the array was 5 MHz and the bandwidth 
was more than 80%. A Ti:Sapphire laser (10 ns pulse) 800 nm 15 mJ cm-2 was used. Detailed 
description of the system can be found elsewhere.3 Anesthetized mouse (Swiss Webster, 3-4 
months old) was depilated and secured to the PACT system. The cortex surface was 
positioned flat and lined up with the imaging plane. Following the PEG-GNS injection, 
continuous monitoring was performed over 2.5 hours. Signal was normalized to the signal of 
the 1st frame. Image series were taken at 1.6 s per frame for the initial 600 seconds followed 
by 60 s per frame until 10000 seconds.  
 
Inflammasome activation study. Bone marrow derived Macrophages (BMDMs) were isolated 
and cultured according to standard procedures. Briefly, bone marrow was isolated from the 
femurs of C57/Bl6 mice and cultured with conditioned DMEM containing 10% FCS and 
Macrophage colony stimulating factor for 6 days before treatment. Cells were seeded onto 96 
well plates and rested overnight. Cells were primed with LPS (100 ng ml-1) for 3 hours and 
treated with nanoparticles for a further 24 h. Supernatants were harvested after which and 
MTS assay (Promega) was used to examine cell viability. ELISA was used to quantify 
cytokines in the supernatants from the various experimental groups used throughout this study. 
IL-1" (R&D Systems), IL-6 (R&D Systems), and TNF# (R&D Systems) were analyzed 
throughout. All ELISAs were conducted a minimum of three times in triplicate. 
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Figure S1. (Left) Hydrodynamic size measured by nanoparticle tracking analysis (NTA) 
found a mode diameter of 80 nm. (Right) Photothermal response of 0.1 nM nanoprobes and 
DI irradiated by 785 nm laser 490 mW.  
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Figure S2. MPM images showing similar intravascular PEG-GNS intensity at 0 min and 100 
min following PEG-GNS (1 pmole) tail vein injection. Size: 0.5x0.5 mm2. 800 nm, 
transmission 0.6%. 
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Figure S3. MPM images of excised whole brain with orthotopic tumor (post-injection 3h). 
Hoescht 33342-stained nuclei are blue. Extensive PEG-GNS (white pattern) distribution can 
be seen in the tumor region but much less in the normal region. Size: 0.5x0.5 mm2. 
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Figure S4. MPM images on cryosectioned brain slice stained with DAPI (blue) and CD31 
(red) from a profused tumor mouse post 48 hours PEG-GNS injection (1 pmole) . (Left) Tile 
image (3.3x3.3 mm2) showing PEG-GNS (white) accumulation at tumor periphery and in 
blood vessels (small white/red punctates). (Right) Zoom-in image (1x1 mm2). T: tumor. N: 
normal.   
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Figure S5. MPM images of DAPI and CD31-stained cyrosectioned brain slices from a 
perfused tumor mouse post-48hr PEG-GNS injection (5 pmole). In normal brain,  PEG-GNS 
was found mostly in the endothelial cells (white colocalizes with red) with minute 
extravasation in the larger vessels (red circles). In tumor brain, PEG-GNS can be seen not 
only in the endothelial cells but also in the perivascular spaces. High concentration PEG-GNS 
may saturate the RES clearance hence accumulating more through the leaky brain tumor 
vasculature. 
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Figure S6. MPM images of DAPI (blue) and CD31 (red)-stained cryosectioned specimens 
from perfused brain excised 48-hr after neutral PEG-GNS (A-E) injection (5 pmole). Large-
area tile images showing distribution of PEG-GNS (A) preferentially in the brain tumor. T: 
tumor. N: normal. Zoom-in images of normal areas (B) and tumor areas (C) showing 
increased extravastion in the tumor regions. Tile images showing accumulation of PEG-GNS 
in liver (D) and kidney (E). Scale bar: 100 µm. 
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Figure S7. MPM images of normal brain side under two different transmission settings 2 
days after photothermal treatment through a cranial window on live mouse. Under the same 
power setting as the tumor side (1% transmission power), only very faint signal can be seen. 
3% transmission power revealed very little PEG-GNS (white) on the vascular wall. This 
suggestion very minimal intravascular or endothelial retention from low dose PEG-GNS 
injection. Image size 500!500 µm2. 
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Figure S8. MPM image of the brain vessels in a tumor mouse (no PEG-GNS injection) 
immediately after the laser irradiation. FITC-dextran (250 kDa, 10mg/kg) was injected prior 
to the laser treatment to visualize the blood vessels. Image size 500!500 µm2. 
 
 
 
 
 
 
 
Figure S9. Induction of TNF# at 3 different time points under 3 different PEG-GNS 
concentrations. With primed macrophages, TNF# level were induced in a concentration 
dependent fashion at 24h incubation. At 2h and 6h, the difference was not apparent.  
